Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

Author:

Ishigami JunichiORCID,Taliercio Jonathan T.,Feldman Harold I.,Srivastava Anand,Townsend Raymond R.,Cohen Debbie L.,Horwitz Edward J.,Rao Panduranga,Charleston Jeanne,Fink Jeffrey C.,Ricardo Ana C.ORCID,Sondheimer JamesORCID,Chen Teresa K.,Wolf Myles,Isakova Tamara,Appel Lawrence J.,Matsushita Kunihiro,

Abstract

BackgroundRisk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through proinflammatory and vitamin D–suppressing pathways. Whether FGF23 is associated with risk of infection has not been evaluated in a CKD population.MethodsIn 3655 participants of the Chronic Renal Insufficiency Cohort study, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hospitalization with major infection, defined by hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia. Multivariable Cox models were used to estimate hazard ratios (HRs) and adjust for confounding.ResultsDuring a median follow-up of 6.5 years, 1051 individuals (29%) were hospitalized with major infection. Multivariable Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1.51; 95% CI, 1.23 to 1.85 with the highest quartile [≥235.9 RU/ml] versus lowest quartile [<95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23). The association was consistent across infection subtypes and demographic and clinical subgroups, and remained significant after additional adjustment for biomarkers of inflammation (IL-6, TNF-α, high-sensitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin D, phosphorus, calcium, and parathyroid hormone). The association was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cases), and bacteremia/septicemia (280 cases).ConclusionsAmong individuals with CKD, higher FGF23 levels were independently and monotonically associated with an increased risk of hospitalization with infection.

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

NIDDK

Perelman School of Medicine at the University of Pennsylvania

NIH

National Center for Advancing Translational Sciences

Johns Hopkins University

University of Maryland

Clinical and Translational Science Collaborative of Cleveland

National Center for Advancing Translational Sciences and NIH Roadmap for Medical Research

Michigan Institute for Clinical and Health Research

University of Illinois at Chicago

Tulane University

Kaiser Permanente Washington Health Research Institute

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Non-Classical Effects of FGF23: Molecular and Clinical Features;International Journal of Molecular Sciences;2024-04-30

2. Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2024-03-06

3. Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism;Clinical Journal of the American Society of Nephrology;2023-09-11

4. Fibroblast Growth Factor 23 in COVID-19: An Observational Study;Cureus;2023-07-27

5. Acute kidney injury and distant organ dysfunction–network system analysis;Kidney International;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3